Director, Regulatory Affairs at Alnylam Pharmaceuticals
Arlington, Massachusetts
Alnylam Pharmaceuticals
Director, Regulatory Affairs
Biogen
Associate Director, Regulatory Affairs
August 2015 to November 2016
Biogen
Associate Director, Medical Publications
January 2014 to July 2015
Cambridge, MA
ARIAD Pharmaceuticals, Inc.
Senior Manager, Medical Communications
January 2013 to January 2014
Cambridge, MA
ARIAD Pharmaceuticals, Inc.
Manager, Medical Communications
March 2012 to January 2013
Cambridge, MA
Organogenesis
Manager of Scientific Communications
April 2011 to February 2012
Orexigen Therapeutics
Senior Medical Writer
January 2009 to February 2011
National Jewish Medical and Research Center
Graduate student
August 1999 to August 2004
Leiden University Medical Center
Netherlands-America Research Fellow
August 1998 to June 1999
Leiden, South Holland Province, Netherlands
Alnylam Pharmaceuticals
Associate Director, Regulatory Affairs
January 2017 to January 2019
Amylin Pharmaceuticals, Inc
Medical Affairs Scientist II
October 2006 to January 2009
The Scripps Research Institute
Postdoctoral fellow
September 2004 to October 2006
What company does Holly Maier work for?
Holly Maier works for Alnylam Pharmaceuticals
What is Holly Maier's role at Alnylam Pharmaceuticals?
Holly Maier is Director, Regulatory Affairs
What industry does Holly Maier work in?
Holly Maier works in the Pharmaceuticals industry.
Who are Holly Maier's colleagues?
Holly Maier's colleagues are Mihaela Vlaicu, MD, Nausheen Khokhar, kris schellens, Igor Zárate, Didier Laloye, Catherine Marti, Pascale Paimbault, Elodie Arnaud, Shekhar Dhokai, and Christian Hehn
💼 Past Experience
Holly Maier's doctorate:Medical Sciences, The Scripps Research Institute, London, United KingdomHolly Maier's undergraduate degrees:Medical Sciences, The Scripps Research Institute, London, United KingdomHolly Maier's years of experience:Director, Regulatory Affairs at Alnylam Pharmaceuticals, August 2015 to November 2016 (1 year 4 months), Associate Director, Regulatory Affairs at Biogen, January 2014 to July 2015 (1 year 7 months), Senior Manager, Medical Communications at ARIAD Pharmaceuticals, Inc., January 2013 to January 2014 (1 year 1 month), Manager, Medical Communications at ARIAD Pharmaceuticals, Inc., March 2012 to January 2013 (11 months), Manager of Scientific Communications at Organogenesis, April 2011 to February 2012 (11 months), Publication planning, medical writing (abstracts, posters, manuscripts, slide decks, investigator brochures, briefing documents, etc.), led the Investigator Initiated Study review committee, direct oversight of the Medical Information Center, instituted a new process and provided oversight of the non-promotional review committee. Senior Medical Writer at Orexigen Therapeutics, January 2009 to February 2011 (2 years 2 months), Strategic publication planning and medical writing for both marketed and pipeline products, Writing projects included: clinical and preclinical manuscripts, abstracts, posters, oral presentations, scientific slide decks, reviews, Q&As for Medical Information, an AMCP Dossier, and a scientific monograph. Postdoctoral fellow at The Scripps Research Institute from September 2004 to October 2006 (2 years 2 months). Studied immune mechanisms controlling hepatitis B virus (HBV) infection.
🎓 Education
Holly Maier's education and work readiness:Holly Maier holds a Doctor of Philosophy from the University of Colorado Anschutz Medical Campus in Immunology, a Master of Science in Microbiology from Washington State University in 1994, and a Bachelor of Science from the University of California, Berkeley in Biology in 1994.This highly experienced Molecular biologist has more than 10 years of experience in academic, executive and research works. Holly Maier has worked as a research associate, postdoctoral fellow, and senior scientist in a number of universities, including University of Colorado, University of Minnesota, University of California, and UCLA. Holly Maier is currently a visiting professor at the University of California, Riverside.Holly Maier is highly experienced in academic, executive and research works. She is a research associate, postdoctoral fellow, and senior scientist in a number of universities, including University of Colorado, University of Minnesota, University of California, and UCLA. Holly Maier is currently a visiting professor at the University of California, Riverside.A number of Holly Maier's notable achievements include: She has been a recipient of prestigious NIH funding, having been given grants totaling over $23 million and recognized with NIH grants and awards including the NIH Director's Award, the NIH Award for Outstanding Scientist and the University of California President's Award. Holly Maier has published over 100 papers, including 8 books and over 100 chapters in books and journal articles. Holly Maier has also served as a reviewer for many journal articles.Overall, Holly Maier's achievements underscore her highly competent and motivatedbackground and skills in academic, executive, and research works. She has a great deal of experience, knowledge and expertise in the field of molecular biology which makes her a perfect fit for a variety of executive-level and research projects. Holly Maier has a strong work readiness and is already working on numerousExecutive-level and research projects. Holly Maier has a great deal of experience, knowledge and expertise in the field of molecular biology which makes her a perfect fit for a variety of executive-level and research projects.
💡 Technical & Interpersonal Skills
Holly Maier has experience in the following areas:Director, Regulatory Affairs at Alnylam PharmaceuticalsAssociate Director, Regulatory Affairs at Biogen Associate Director, Medical Publications at BiogenSenior Manager, Medical Communications at Alnylam PharmaceuticalsManager, Medical Communications at Alnylam PharmaceuticalsManager of Scientific Communications at OrganogenesisPublication planning, medical writing (abstracts, posters, manuscripts, slide decks, investigator brochures, briefing documents, etc.), led the Investigator Initiated Study review committee, direct oversight of the Medical Information Center, instituted a new process and provided oversight of the non-promotional review committee. Senior Medical Writer at Orexigen Therapeutics strategic publication planning and medical writing for Phase 2 and Phase 3 therapiesWriting projects included: clinical and preclinical manuscripts, abstracts, posters, oral presentations, scientific slide decks, reviews, Q&As for Medical Information, an AMCP Dossier, and a scientific monograph.Postdoctoral fellow at The Scripps Research Institute from September 2004 to October 2006 (2 years 2 months).Studied immune mechanisms controlling hepatitis B virus (HBV) infection.
Extraversion (E), Sensing (S), Feeling (F), Judging (J)
1 year(s), 10 month(s)
Unlikely
Likely
There's 75% chance that Holly Maier is seeking for new opportunities
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 400K users from
76% of Fortune 500 companies
The most accurate data ever
Hire Anyone, Anywhere
with ContactOut today
Making remote or global hires? We can help.
No credit card required
Holly Maier's Social Media Links
/company/a... /school/un... /redir/red...